Profile data is unavailable for this security.
About the company
Laboratory Corporation of America Holdings provides comprehensive laboratory services that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. By leveraging its unparalleled diagnostics and drug development capabilities, the Company provides insights and accelerates innovations to improve health and improve lives. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company serves clients in more than 100 countries.
- Revenue in USD (TTM)12.30bn
- Net income in USD399.20m
- Incorporated1994
- Employees67.00k
- LocationLaboratory Corporation of America Holdings358 S MAIN STBURLINGTON 27215-5837United StatesUSA
- Phone+1 (336) 229-1127
- Fax+1 (302) 636-5454
- Websitehttps://www.labcorp.com
More ▼
Mergers & acquisitions
| Acquired company | LH:NYQ since announced | Transaction value |
|---|---|---|
| Baystate Health Inc-Outreach Laboratory business | 0.42% | -- |
| Tufts Medicine-Outreach Laboratory Business | -6.34% | -- |
| Legacy Health System-Outreach Laboratory Select Assets | -4.35% | -- |
| Providence Medical Group,Portland,Oregon-Outreach Laboratory business | -9.68% | -- |
| Jefferson Health LLC-Outreach Laboratory business | -10.90% | -- |
Data delayed at least 15 minutes, as of May 02 2024 00:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemed Corp | 2.29bn | 283.41m | 8.60bn | 15.09k | 30.58 | 7.24 | 24.90 | 3.75 | 18.58 | 18.58 | 150.33 | 78.46 | 1.45 | 138.48 | 13.85 | 152,017.80 | 17.94 | 19.53 | 21.86 | 24.64 | 35.47 | 34.60 | 12.36 | 12.60 | 1.88 | -- | 0.0114 | 8.15 | 6.06 | 4.90 | 9.17 | 5.80 | 1.46 | 6.10 |
| Tenet Healthcare Corp | 20.90bn | 2.62bn | 11.14bn | 78.14k | 4.34 | 3.23 | 2.65 | 0.533 | 25.87 | 25.87 | 201.91 | 34.81 | 0.7466 | 9.04 | 6.70 | 267,391.00 | 11.97 | 3.61 | 17.38 | 5.09 | 82.64 | 82.97 | 16.03 | 4.95 | 1.37 | 4.39 | 0.6267 | 0.00 | 7.17 | 2.33 | 49.02 | 41.42 | 4.01 | -- |
| Solventum Corp | 8.20bn | 1.35bn | 11.23bn | 22.01k | 8.33 | 0.9624 | 5.89 | 1.37 | 7.80 | 7.80 | 47.53 | 67.55 | -- | -- | -- | 372,472.40 | -- | -- | -- | -- | 57.25 | -- | 16.42 | -- | 0.9618 | -- | 0.00 | -- | 0.8241 | -- | 0.2234 | -- | -- | -- |
| Universal Health Services, Inc. | 14.66bn | 816.29m | 11.36bn | 73.35k | 14.45 | 1.83 | 8.17 | 0.7751 | 11.79 | 11.79 | 211.29 | 93.13 | 1.06 | -- | 6.77 | 199,837.00 | 5.96 | 6.44 | 6.98 | 7.63 | -- | -- | 5.61 | 6.55 | 1.28 | 6.16 | 0.4352 | 6.06 | 6.59 | 5.80 | 6.32 | -1.47 | 1.17 | 14.87 |
| Davita Inc | 12.14bn | 691.54m | 12.19bn | 70.00k | 18.76 | 11.69 | 7.16 | 1.00 | 7.41 | 7.41 | 130.29 | 11.89 | 0.7179 | 65.97 | 5.89 | 173,430.70 | 5.66 | 5.62 | 7.55 | 7.45 | 31.47 | 30.70 | 7.88 | 8.33 | 1.13 | 4.77 | 0.7536 | -- | 4.57 | 1.26 | 26.44 | 2.33 | -10.47 | -- |
| Quest Diagnostics Inc | 9.29bn | 842.00m | 15.35bn | 40.00k | 18.59 | 2.38 | 11.65 | 1.65 | 7.43 | 7.43 | 82.00 | 57.95 | 0.6944 | 33.57 | 7.21 | 232,175.00 | 6.51 | 9.28 | 7.61 | 10.81 | 32.95 | 36.64 | 9.37 | 12.97 | 0.8908 | 8.40 | 0.4184 | 25.07 | -6.38 | 4.20 | -9.77 | 3.40 | 1.27 | 7.43 |
| Laboratory Corporation of Amerc Holdings | 12.30bn | 399.20m | 16.94bn | 67.00k | 44.09 | 2.13 | 17.53 | 1.38 | 4.57 | 4.95 | 142.45 | 94.42 | 0.6698 | 18.59 | 4.68 | 183,588.10 | 2.18 | 6.27 | 2.68 | 7.37 | 27.74 | 32.33 | 3.25 | 9.51 | 0.7564 | 6.37 | 0.3934 | -- | 2.51 | 1.42 | -62.16 | -16.40 | 3.62 | -- |
| Molina Healthcare Inc | 35.85bn | 1.07bn | 20.05bn | 18.00k | 18.56 | 4.49 | 16.13 | 0.5591 | 18.43 | 18.43 | 617.11 | 76.15 | 2.48 | -- | 12.18 | 1,991,889.00 | 7.42 | 7.62 | 16.79 | 16.80 | 15.74 | 15.99 | 2.99 | 3.04 | -- | 14.69 | 0.3465 | 0.00 | 6.56 | 12.52 | 37.75 | 9.06 | 22.87 | -- |
Data as of May 02 2024. Currency figures normalised to Laboratory Corporation of America Holdings's reporting currency: US Dollar USD
36.15%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2023 | 9.38m | 11.16% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 4.61m | 5.48% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 3.77m | 4.48% |
| Wellington Management Co. LLPas of 31 Dec 2023 | 2.25m | 2.67% |
| BlackRock Advisors LLCas of 31 Dec 2023 | 2.24m | 2.66% |
| Geode Capital Management LLCas of 31 Dec 2023 | 1.87m | 2.22% |
| Lazard Asset Management LLCas of 31 Dec 2023 | 1.82m | 2.17% |
| Allspring Global Investments LLCas of 31 Mar 2024 | 1.59m | 1.89% |
| Dimensional Fund Advisors LPas of 31 Dec 2023 | 1.45m | 1.72% |
| Diamond Hill Capital Management, Inc.as of 31 Dec 2023 | 1.42m | 1.69% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
